Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTICOP: Corticosteroids vs placebo for ventilator-free days in severe COPD exacerbations
2019-001726-99Phase 3Active
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Jun 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Systemic corticosteroids with Placebo (2 arms). Primary endpoint: Ventilator-free days and alive at day 28. Started Jun 2019; status: active.
02
Drugs
corticosteroids
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2019-001726-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001726-99.